Status:
RECRUITING
A Study to Explore the Role and Impact of Wearable Smart Devices in Perioperative NSCLC Patients
Lead Sponsor:
The First Affiliated Hospital of Guangzhou Medical University
Conditions:
Non Small Cell Lung Cancer
Eligibility:
All Genders
18+ years
Brief Summary
The trial was designed as a single-center non-interventional prospective observational study to explore the role and impact of wearable smart devices in perioperative NSCLC patients.
Eligibility Criteria
Inclusion
- Participants must provide voluntary consent to participate in this research and possess the capacity to sign an informed consent form.
- Participants must be aged over 18 years.
- Participants must have undergone pulmonary resection surgery with a postoperative pathological confirmation of primary lung cancer.
Exclusion
- Patient refusal to participate in this research.
- Inability to wear wearable smart monitoring devices due to various reasons.
- The pathological report suggests a non-small cell lung cancer (NSCLC) exclusion.
- History of secondary lung cancer surgery.
Key Trial Info
Start Date :
March 9 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 31 2026
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT06118229
Start Date
March 9 2023
End Date
March 31 2026
Last Update
June 28 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Thoracic Surgery and Oncology, The First Affiliated Hospital of Guangzhou Medical University
Guangzhou, Guangdong, China